This article is part of a special issue entitled: ‘EPN 100 years’ published in Journal of Invertebrate Pathology, The field of entomopathogenic nematology has grown exponentially since the discovery of the first species, Steinernema kraussei (=Aplecatna kraussei), in 1923. Initially, entomopathogenic nematodes (EPN) were solely viewed as a curiosity. The discovery of the nematode-bacteria association in 1965 and the incipient research for mass production motivated their recognition as biological control agents for agricultural pests. Subsequent studies were focused on the discovery of new species and/or populations, the early studies to understand the biotic and abiotic factors that contribute to their performance in the field and success in insect pest management. However, as we entered the 21st century, and with the advent of molecular biology, research on these organisms took a fascinating turn, unraveling a deeper understanding of the complex symbiotic relationship EPN has with their bacterial symbionts and the insect host. Furthermore, because of their experimental tractability, EPNs have proven to be model organisms that are used among various biological sciences to gain further insights into host-symbiont, host-pathogen interactions, population dynamics, and as resources for pharmaceutical bioprospecting. This special issue commemorates the first 100 years of research in entomopathogenic nematology and summarizes the contributions of ten symposia and presentations at the 100th Anniversary of the First EPN Discovery Congress in Logroño, Spain (https://www.icvv.es/english/epn). This specific article focuses on the historical review of EPN, their bacterial partners and the numerous and diverse applications in disciplines in basic such as phylogeny, biogeography, symbiosis, and soil biology and ecology, or more applied venues such as formulation and mass production, application technology, commercialization and regulation, from 1923 to the present time., SPS acknowledges the Agricultural Research Institute (ARI) from California State University for providing partial support to attend the EPN 100 Anniversary Conference in Logroño Spain. RCH was also supported by the frame of the Grant PID2022-136487OB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and, by “ERDF A way of making Europe”., Peer reviewed

The collaboration among academia, industry, and government is crucial for scientific progress and innovation. Academia generates fundamental knowledge, which industry translates into sound applications, considering government policies. This partnership is vital to feed progress and constant development and address global challenges like climate change and food security. Sustainable crop protection is a topical theme, with efforts to reduce pesticide reliance and promote alternatives to chemical pest management, and it continues to grow and be accepted worldwide. In this respect, biopesticides such as entomopathogenic nematodes (EPNs) offer a promising solution for pest and disease management as an eco-friendly alternative. However, EPN continue to face adoption barriers due to regulatory, commercialization and basic and applied knowledge gaps. Thus, stronger collaborations are needed to unlock their full potential, as highlighted in the 2024 congress organized in La Rioja (Spain) to commemorate the 100 years since the discovery of the first EPN. This review examines the gap between academia and industry, suggesting strategies to bridge it, thereby promoting the advancement of EPN in 21st-century agriculture. Despite decades of research demonstrating their efficacy, EPN commercialization remains limited by production, formulation, and application challenges. Universities and government research agencies have driven fundamental innovation through the discovery of new EPN-bacteria partnerships in new regions of the world, which are helping us understand their distribution and habitant adaptations which are required for their registration and in establishing global regulations. Research conducted both in academia and the private sector (both big and small start-up companies) has and continues to play a key role in the characterization of EPN and in assessing their performance for their subsequent formulation, product optimization, and commercialization. These are fundamental steps to reach the ultimate goal, which is to provide growers with reliable products that are cost-effective and sustainable. In this review, we summarize key findings that have led to the commercialization and application of EPN, spanning from the characterization of EPN and their symbiotic bacteria to production, formulation, and the requirements for their registration. We also highlight critical knowledge gaps and opportunities for collaboration between academia, government agencies, and industry. Strengthening these partnerships will drive EPN adoption in agriculture, establishing them as a desirable biocontrol solution., RCH acknowledges grant PID2022-136487OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” associated with the ideas presented in this manuscript., Peer reviewed